Supriya Lifescience Limited (SUPRIYA) — Financial Flexibility Index
Supriya Lifescience Limited (SUPRIYA) has a Financial Flexibility Index of 0.81x as of September 2025. Free cash flow of Rs978.14 Million (operating CF Rs555.65 Million minus capex Rs422.49 Million) represents 1% of total liabilities (Rs1.21 Billion). Also explore SUPRIYA net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Supriya Lifescience Limited Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Supriya Lifescience Limited across 8 annual periods. Check SUPRIYA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Supriya Lifescience Limited (2018–2025)
Year-by-year free cash flow to debt coverage for Supriya Lifescience Limited. For the full company profile including market capitalisation, see SUPRIYA company net worth.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.90x | Rs3.35 Billion | Rs1.73 Billion | Rs1.16 Billion | ▲ +18.5% |
| 2024 | 2.45x | Rs2.59 Billion | Rs1.13 Billion | Rs1.06 Billion | ▲ +69.3% |
| 2023 | 1.45x | Rs1.75 Billion | Rs661.87 Million | Rs1.21 Billion | ▲ +58.3% |
| 2022 | 0.91x | Rs1.09 Billion | Rs488.01 Million | Rs1.19 Billion | ▲ +26.0% |
| 2021 | 0.72x | Rs1.28 Billion | Rs799.30 Million | Rs1.77 Billion | ▼ -3.5% |
| 2020 | 0.75x | Rs1.41 Billion | Rs1.16 Billion | Rs1.87 Billion | ▲ +115.0% |
| 2019 | 0.35x | Rs556.17 Million | Rs486.72 Million | Rs1.59 Billion | ▲ +197.6% |
| 2018 | 0.12x | Rs223.82 Million | Rs174.52 Million | Rs1.91 Billion | — |